Clinical Trial Update: Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Pembrolizumab is being evaluated in a Phase 2 trial for cervical intraepithelial neoplasia and related cervical lesions, with patient recruitment currently ongo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia
• Cervical Squamous Cell Carcinoma in Situ
• Cervical Squamous Intraepithelial Neoplasia

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Cervical Intraepithelial Neoplasia, Cervical Squamous Cell Carcinoma In Situ | Phase 2 | Status: RECRUITING